Cleveland Clinic Taussig Cancer Institute

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Cleveland Clinic Taussig Cancer Institute

Taussig Cancer Institute is the hub for Cleveland Clinic Cancer Center.

2024 Management of Checkpoint Inhibitor-Related Toxicity
8th Annual Cleveland Breast Cancer Summit
2024 ASH Review
2023 Breast Cancer Update: Review of Breast Cancer Symposia
2023 Management of Checkpoint Inhibitor-Related Toxicity
2022 Management of Checkpoint Inhibitor-Related Toxicities
2022 Breast Cancer Update: Review of Breast Cancer Symposium
2021 Management of Checkpoint Inhibitor-Related Toxicity
Breast Cancer Update: Review of Breast Cancer Symposia
7th Annual Multidisciplinary Colorectal Oncology Course
ASCO 2020 Highlights
20th Annual ASH Review
Benign Hematology Malignant Hematology
2020 Management of Checkpoint Inhibitor-Related Toxicity
Common but Complex irAEs It Isn’t Just Joint Pain Common and Emergent irAEs Rare and Fatal irAEs
2020 Multidisciplinary Head and Neck Cancer Update
HPV/Oropharynx/Re-treatment/Personalized Radiotherapy/Value-based Care Oral Cavity/Melanoma/Non-melanoma Skin Larynx/Thyroid Salivary Gland/Paranasal Sinus/Parapharyngeal Space Tumors/QOL/Immunotherapy
6th Annual Multidisciplinary Colorectal Oncology Course
Rectal Cancer CRC in the Young Patient Survivorship Metastatic Colon Cancer
5th Annual Cleveland Breast Cancer Summit
Breast Cancer Management Breast Cancer Cases
5th Annual Multidisciplinary Colorectal Oncology Course
Breast
GI
GU
Skin
Lymphoma
Leukemia
Lung
Gyn
MDS/MPN
Benign Hematology
Myeloma
Hematologic Malignancies
Events
Updates in Melanoma and High Risk Skin Cancer Management

Playback speed

10 seconds

Suspected Checkpoint Inhibitor-Related Cholecystitis in Patients With Metastatic Melanoma

By Cleveland Clinic's 2022 Management of Checkpoint Inhibitor-Related Toxicities FEATURING Danai Dima

12 views

March 17, 2022

Comments 0

First-line Maintenance Treatment Option in Patients With HRD-Positiv…

Feat. S. Lewin

Expert Case Review: A Treatment Option for Adult Patients With Stage…

Feat. A. Whiteley

2022 Management of Checkpoint Inhibitor-Related Toxicities

Management of Immune Checkpoint Inhibitors Related Colitis

Cleveland Clinic's 2022 Management of Checkpoint Inhibitor-Related Toxicities

Y. Wang

178 views

Hepatotoxicity From Immune Checkpoint Inhibitors

Cleveland Clinic's 2022 Management of Checkpoint Inhibitor-Related Toxicities

M. Whitsett

124 views

Combined Immune CPI-Related Pancreatic AEs: A Systematic Review and …

Cleveland Clinic's 2022 Management of Checkpoint Inhibitor-Related Toxicities

A. Palash

84 views

Suspected Checkpoint Inhibitor-Related Cholecystitis in Patients Wit…

Cleveland Clinic's 2022 Management of Checkpoint Inhibitor-Related Toxicities

D. Dima

12 views

Case Presentations/Panel Discussion: 67 y/o With Stage 4 Lung Cancer…

Cleveland Clinic's 2022 Management of Checkpoint Inhibitor-Related Toxicities

J. Philpott, Y. Wang, M. Whitsett, A. Palash, D. Dima

21 views

Update in Cutaneous irAEs

Cleveland Clinic's 2022 Management of Checkpoint Inhibitor-Related Toxicities

A. Fernandez

32 views

Identification and Management of Endocrine irAEs

Cleveland Clinic's 2022 Management of Checkpoint Inhibitor-Related Toxicities

C. Nasr

37 views

Case Presentations/Panel Discussion: 45 y/o Male With Metastatic Mel…

Cleveland Clinic's 2022 Management of Checkpoint Inhibitor-Related Toxicities

B. Estfan, A. Fernandez, C. Nasr

22 views

Rheumatic irAEs From CPI Therapy

Cleveland Clinic's 2022 Management of Checkpoint Inhibitor-Related Toxicities

C. Calabrese

88 views

Central Nervous System irAEs

Cleveland Clinic's 2022 Management of Checkpoint Inhibitor-Related Toxicities

A. Kunchok

106 views

Case Presentations/Panel Discussion: 68 y/o Male With Stage 4 RCC, 6…

Cleveland Clinic's 2022 Management of Checkpoint Inhibitor-Related Toxicities

M. Ornstein, C. Calabrese, A. Kunchok

36 views

Long Term Sequelae of irAEs & Management of Steroid Use

Cleveland Clinic's 2022 Management of Checkpoint Inhibitor-Related Toxicities

J. Song

25 views

The Role of Nursing in the Management of Immune CPI Toxicities

Cleveland Clinic's 2022 Management of Checkpoint Inhibitor-Related Toxicities

L. Kottschade

12 views

Case Presentations/Panel Discussion: 45 y/o Male With Metastatic Mel…

Cleveland Clinic's 2022 Management of Checkpoint Inhibitor-Related Toxicities

L. S Wood, J. Song, L. Kottschade, C. Stenek, T. Plues, E. Coles-Herman

44 views

Nephrologic irAEs: The Kidneys and Checkpoint Inhibitors

Cleveland Clinic's 2022 Management of Checkpoint Inhibitor-Related Toxicities

A. Mehdi

154 views

Diagnosis and Management of Ophthalmic Complications of Checkpoint I…

Cleveland Clinic's 2022 Management of Checkpoint Inhibitor-Related Toxicities

S. Sharma

52 views

Case Presentations/Panel Discussion: 68 y/o Male H&N Cancer Patient …

Cleveland Clinic's 2022 Management of Checkpoint Inhibitor-Related Toxicities

J. Geiger, A. Mehdi, S. Sharma

33 views

Immune Checkpoint Inhibitor-Mediated Adverse Cardiac Events

Cleveland Clinic's 2022 Management of Checkpoint Inhibitor-Related Toxicities

R. Moudgil

47 views

Pulmonary Immune-Related Adverse Events

Cleveland Clinic's 2022 Management of Checkpoint Inhibitor-Related Toxicities

N. Thiruchelvam

55 views

irAE Management of the Oncology Patient in the ICU

Cleveland Clinic's 2022 Management of Checkpoint Inhibitor-Related Toxicities

S. Mucha

98 views

Case Presentations/Panel Discussion: 80 y/o M With Melanoma, 67 y/o …

Cleveland Clinic's 2022 Management of Checkpoint Inhibitor-Related Toxicities

J. Stevenson, R. Moudgil, N. Thiruchelvam, S. Mucha

46 views

Hematologic irAEs (VTEs)

Cleveland Clinic's 2022 Management of Checkpoint Inhibitor-Related Toxicities

K. McCrae

117 views

CAR T-Cell Therapies: Immunoinflammatory Toxicities

Cleveland Clinic's 2022 Management of Checkpoint Inhibitor-Related Toxicities

P. Caimi

49 views

Case Presentations/Panel Discussion: 58 y/o F With mNSCLC, 32 y/o M …

Cleveland Clinic's 2022 Management of Checkpoint Inhibitor-Related Toxicities

P. Patil, K. McCrae, P. Caimi

19 views